Table II.
Group | NREM phase 1 (min) | NREM phase 2 (min) | NREM phase 3 (min) | NREM phase 4 (min) | REM (min) |
---|---|---|---|---|---|
ECO | 23.94±13.27 | 260.02±30.71 | 47.00±16.57 | 73.88±13.31 | 126.19±35.01 |
E-AED I | 29.50±10.61 | 260.02±30.71 | 42.79±6.27 | 70.48±9.62 | 116.99±12.90 |
E-AED II | 92.10±48.24 | 240.96±42.92 | 51.19±8.75 | 70.96±24.90 | 70.82±17.69 |
P-value | <0.01 | >0.05 | >0.05 | >0.05 | <0.01 |
Data are expressed as the mean ± SD. E-AED I, duration of VPA administration <3 months; E-AED II, duration of VPA administration >3 months; ECO, without VPA; VPA, sodium valproate; NREM, non-rapid eye movement; REM, rapid eye movement.